ログイン

Child Psych Anxiety

Child Psych Anxiety
56問 • 11ヶ月前
  • Two Clean Queens
  • 通報

    問題一覧

  • 1

    Is the emotional response to real or perceived imminent threat. Often associated with surges of autonomic arousal necessary for fight or flight, thoughts of immediate danger, and escape behaviors.

    Fear

  • 2

    Is anticipation of future threat. More often associated with muscle tension and vigilance in preparation for future danger and cautious or avoidant behaviors.

    Anxiety

  • 3

    Normal fears from birth to 6 months

    -Loss of physical support -Loud noises -Large rapidly approaching objects

  • 4

    Normal fears 7-12 months

    Strangers

  • 5

    Normal fears 1-5 years old

    -Loud noises -Stroms -Animals -The dark -Separation from parents

  • 6

    Normals fears for 3-5 year olds

    -Monsters -Ghosts -Punishment

  • 7

    Normal fears for 6-12 year olds

    -Bodily injury/sickness -Burglars -Being sent to the principal -Punishment -Natural disasters -Failure/rejection

  • 8

    Normal fears 12-18 years old

    -Tests in school -Low social competence -Social evaluation -Social embarrassment -Psychological abnormality

  • 9

    Fear of being separated from a caregiver, fear of harm to self or caregiver when separated

    Seperation anxiety disorder

  • 10

    Consistent reduced communication (e.g., not speaking) in at least one environment despite ability to speak

    Selective mutism

  • 11

    Fear of negative evaluation

    Social anxiety disorder

  • 12

    Fear of a particular situation or object

    Specific phobias

  • 13

    Fear of the physiological sensations of anxiety and of having a panic attack

    Panic disorder

  • 14

    Worry about a broad range of topics

    Generalized anxiety disorder

  • 15

    Anxiety disorder in childhood adolescents predict a range of psychiatric disorders in adulthood

    ◦ Anxiety disorders, mood disorders, and substance abuse ◦ Lack of social competence ◦ Reduced social relationship functioning ◦ Reduced occupational functioning

  • 16

    ◦ Normal uncertainty and anxious or insecure attachment ◦ Maintenance of symptoms conditioned by fear, reinforcement ◦ Attachment theory - insecure mother-infant attachment and maternal sensitivity each separately predicted separation anxiety in children at age 6 years

    Etiology: Developmental and Behavioral

  • 17

    ◦ Dysregulation of fear and stress response system in the brain ◦ Behavioral inhibition - genetically based temperament trait characterized by response to a new or unfamiliar situation with avoidance, distress, caution, and/or reticence.

    Etiology: Biological

  • 18

    ◦ Parenting styles characterized by rejection, control, and intrusiveness are also likely related to increased anxiety in youth ◦ Parental modeling and exposure to negative information (SOC, Panic disorder, GAD)

    Etiology: Environmental

  • 19

    Hallmarks of Anxiety in Children and Adolescents

    • Somatic symptoms: stomach aches, headaches, sore muscles • Cognitive symptoms: difficulty with attention, concentration, organization and/or decision making • Social avoidance: school refusal • Affective symptoms: irritability, tearfulness, aggression (in adolescents), increased temper tantrums (in younger children) • Avoidance of age appropriate tasks • Noticeable decline in school performance or increased procrastination • Inability to complete assignments on time • Increased need for routines or increases distress in variations to routine; attempts to control others’ behaviors • Restlessness or increased startle response • Sleep disturbances

  • 20

    Ages 8-19: GAD, panic/agoraphobia, social phobia, SAD, OCD, and physical symptoms, harm avoidance

    Multidimensional Anxiety Scale for Children (MASC)

  • 21

    Ages 9-18; GAD SOC, phobic disorders, SAD

    Screen for Child Anxiety and Related Emotional Disorders (SCARED)

  • 22

    Ages: 8-15; GAD, panic/agoraphobia, social phobia, SAD, OCD, and physical injury fears

    Spence Children’s Anxiety Scale (SCAS)

  • 23

    Ages 2.5-6.5 (Based on the SCAS)

    Preschool Anxiety Scale

  • 24

    Ages 6-17; GAD, general and social phobia, SAD

    Pediatric Anxiety Rating Scale (PARS)

  • 25

    When moderate to severe anxiety symptoms persist what SSRIs can we use and what age range?

    -FDA approved for 7+ -Citalopram -Fluoxetine -Fluvoxamine -Paroxetine -Sertraline

  • 26

    What are the SNRIs for child and adolescents?

    -Venlafaxine -Duloxetine

  • 27

    Benzos used in child and adolescents?

    -Clonazepam -Alprazolam -Lorazepam

  • 28

    Non-benzodiazepine (0.2-0.6 mg/kg; BID or TID – indicated for OCD, GSD, SOC) SE: lightheadedness, dizziness, nausea, sedation

    Buspirone

  • 29

    -Tertiary TCA (2.0-5.0 mg/kg; daily or BID – indicated for OCD and school refusal) -SE: Anticholinergic

    Clomipramine

  • 30

    -Tertiary TCA (2.0-5.0 mg/kg; daily or BID – indicated for GAD and panic disorder) -SE: cardiac toxicity and EKG changes

    Imipramine

  • 31

    -Secondary TCA (2.0-5.0 mg/kg; daily or BID – indicated for OCD) -SE: cardiac toxicity and EKG changes

    Despiramine

  • 32

    -Developmentally inappropriate and excessive fear or anxiety concerning separation from those to whom the individual is attached -Recurrent excessive distress when anticipating or experiencing separation from home or from major attachment figures. -Persistent and excessive worry about losing major attachment figures or about possible harm to them -Persistent and excessive worry about experiencing an untoward event (e.g., getting lost, being kidnapped, having an accident, becoming ill) that causes separation from a major attachment figure. -Persistent reluctance or refusal to go out because of fear of separation. -Persistent and excessive fear of or reluctance about being alone or without major attachment figures at home or in other settings. -Persistent reluctance or refusal to sleep away from home or to go to sleep without being near a major attachment figure. -Repeated nightmares involving separation. -Repeated complaints of physical symptoms (e.g., headaches, stomachaches, nausea, vomiting) when separation from major attachment figures occurs or is anticipated. -The fear, anxiety, or avoidance is persistent, lasting at least 4 weeks -The disturbance causes clinically significant distress or impairment -The disturbance is not better explained by another mental disorder

    DSM-5 Criteria: Separation Anxiety Disorder (SAD)

  • 33

    Duration of Separation Anxiety Disorder (SAD)

    Duration: 4-6 weeks in children and adolescents; 6 months in adults

  • 34

    Epidemiology of Separation Anxiety Disorder (SAD)

    Overall prevalence: 3-5% 6 to 12-month prevalence -In children: 4% -In adolescents: 1.6% Decreases in prevalence with age ◦ Most prevalent in children <12 years old Equally common in males and females in clinical samples ◦ Females>males in community samples 75% of children with SAD exhibit school avoidance behaviors ◦ Absenteeism ◦ Refusal

  • 35

    Separation anxiety is a normal developmental phenomenon in

    Children ages 6–30 months, with intensification between 13 and 18 months of age

  • 36

    -Consistent failure to speak in specific social situations in which there is an expectation for speaking (e.g., at school) despite speaking in other situations. -The disturbance interferes with educational or occupational achievement or with social communication. -The duration of the disturbance is at least 1 month (not limited to the first month of school). -The failure to speak is not attributable to a lack of knowledge of, or comfort with, the spoken language required in the social situation. -The disturbance is not better explained by a communication disorder (e.g., childhood-onset fluency disorder) and does not occur exclusively during the course of autism spectrum disorder, schizophrenia, or another psychotic disorder.

    DSM-5 Criteria: Selective Mutism

  • 37

    Relatively rare ◦ Prevalence between 0.03%-1% depending on the setting (e.g., clinic vs. school vs. community) Most likely to occur in young children rather than adolescents ◦ Onset usually before age 5; may not be clinically relevant until attendance in school -Common in males and females -Persistence varies; however, most outgrow -Longitudinal course is unknown

    Epidemiology and Etiology: Selective Mutism

  • 38

    ◦ Shyness ◦ Behavioral inhibition ◦ Receptive language difficulties (although still within normal range) ◦ Social isolation/anxiety

    Temperamental Risks: Selective Mutism

  • 39

    ◦ Parental modeling ◦ Overprotective parenting or more controlling ◦ Genetic factors ◦ May be shared genetic factors that are associated with social anxiety disorder

    Environmental Risks: Selective Mutism

  • 40

    Noted usually at the start of kindergarten or 1st grade ◦ Most are diagnosed between ages 3-8 -Resolves by age of 10; if continues beyond 12 years, full recoverly less likely -SM leads to complications in academic achievement and peer relationships ◦ May lead to placement in special education classes or schools -May develop social anxiety disorder in adulthood

    Course and Prognosis: Selective Mutism

  • 41

    -Marked fear or anxiety about one or more social situations in which the individual is exposed to possible scrutiny by others. -The individual fears that he or she will act in a way or show anxiety symptoms that will be negatively evaluated -The social situations almost always provoke fear or anxiety. -The social situations are avoided or endured with intense fear or anxiety. -The fear or anxiety is out of proportion to the actual threat posed by the social situation/context -Must last 6 months or more

    DSM-5 Criteria: Social anxiety disorder (SAD)

  • 42

    Blushing in a hallmark sign of this disorder

    Social Anxiety Disorder (SAD)

  • 43

    -Prevalence: 5% in children and 16% in youths 13-17 years -More common in girls and younger children

    Epidemiology: Specific Phobias

  • 44

    Prevalence: 2-5% children, 9% in adolescents ◦ Lifetime: 16%

    Epidemiology: Social Anxiety Disorder (SAD)

  • 45

    Median age of onset: 13 years ◦ Age of onset between 8 and 15 years for 75% of individuals ◦ May follow a stressful or humiliating experience, or an experience which may require a new social role ◦ Adolescents may have broad patters of fear and avoidance, in comparison to younger children ◦ 30% experience remission of symptoms within 1 year ◦ 50% within a few years ◦ 60% without a specific treatment, it may take several years or longer

    Development and Course: Social Anxiety Disorder (SAD) and Specific Phobias

  • 46

    ◦ Tends to begin in adolescence ◦ Stressful life events may play a role ◦ Impact functioning into adulthood if symptoms persist (Similar to SAD outcomes)

    Course and Prognosis: Social Anxiety Disorder

  • 47

    ◦ Can begin at any time during development ◦ Usually associated with an unexpected panic attack or traumatic event ◦ Often resolve spontaneously ◦ Those with natural-environment type phobias tend to fare poorly and are more difficult to treat than those with animal-type phobias

    Course and Prognosis: Specific Phobias

  • 48

    Characterized by social evaluative concerns; fear that the individual makes other people uncomfortable

    Taijin kyofusho syndrome

  • 49

    Recurrent unexpected panic attacks. A panic attack is an abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, and during which time four (or more) of the following symptoms occur: 1. Palpitations, pounding heart, or accelerated heart rate. 2. Sweating. 3. Trembling or shaking. 4. Sensations of shortness of breath or smothering. 5. Feelings of choking. 6. Chest pain or discomfort. 7. Nausea or abdominal distress. 8. Feeling dizzy, unsteady, light-headed, or faint. 9. Chills or heat sensations. 10. Paresthesias (numbness or tingling sensations). 11. Derealization (feelings of unreality) or depersonalization (being detached from oneself). 12. Fear of losing control or “going crazy.” 13. Fear of dying. At least one of the attacks has been followed by 1 month (or more) of one or both of the following: 1. Persistent concern or worry about additional panic attacks or their consequences 2. A significant maladaptive change in behavior related to the attacks

    DSM-5 Criteria: Panic Disorder

  • 50

    Age of onset in U.S.: 20-24 years old ◦ Small numbers in childhood, rare ◦ More common in adolescents 12-month prevalence: 2-3% in adolescents and adults in U.S. and European countries Ethnic differences within the U.S. ◦ Lower rates: Latino, African American, Caribbean blacks, and Asian Americans (0.1-0.8%) ◦ Higher rates: American Indians Male:Female ratio is 1:2 ◦ Occurs is adolescence and usually observable prior to age 14 Possibly a genetic component based on twin studies Panic disorder increases in adolescence and peaks during adulthood, often declining in the older adult If untreated, can wax and wane for years

    Epidemiology: Panic Disorder

  • 51

    -Natural history and course are unclear -Likely to be a chronic disorder as often co-occurring with other anxiety and mood disorders, including ADHD -Prepubertal onset usually signals greater severity -Can begin at the onset of or during an episode of major depression or SAD

    Course and Prognosis: Panic Disorder

  • 52

    -Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 months, about a number of events or activities (such as work or school performance). -The individual finds it difficult to control the worry. -The anxiety and worry are associated with three (or more) of the following six symptoms (with at least some symptoms having been present for more days than not for the past 6 months): 1. Restlessness or feeling keyed up or on edge. 2. Being easily fatigued. 3. Difficulty concentrating or mind going blank. 4. Irritability 5. Muscle tension. 6. Sleep disturbance (difficulty falling or staying asleep, or restless, unsatisfying sleep). -The anxiety, worry, or physical symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning

    DSM-5 Criteria: Generalized Anxiety Disorder

  • 53

    Common symptoms may include ◦ Nail biting ◦ Hair pulling ◦ Thumb sucking ◦ Licking around the mouth ◦ Somatic symptoms (see picture)

    Generalized Anxiety Disorder

  • 54

    Average age of onset: early 30s Transient symptoms may be developing in children due to other anxiety disorders or depression Prevalence: 1 -3% in adolescents Male: Female ratio: 1:2

    Epidemiology: Generalized Anxiety Disorder

  • 55

    -Chronic disorder with low rates of full remission -Improvement is variable due to the waxing and waning nature of the disorder (with or without treatment) If diagnosed in childhood ◦ Likely due to heritable traits ◦ May exhibit more severe symptoms and impairment ◦ Increased risk for the development of a range of disorders across the life span

    Course and Prognosis: Generalized Anxiety Disorder

  • 56

    What phobias are equal in boys and girls?

    Blood-injection injury

  • Patho Renal

    Patho Renal

    Two Clean Queens · 100問 · 2年前

    Patho Renal

    Patho Renal

    100問 • 2年前
    Two Clean Queens

    Pathophysiology

    Pathophysiology

    Two Clean Queens · 100問 · 2年前

    Pathophysiology

    Pathophysiology

    100問 • 2年前
    Two Clean Queens

    Patho Immunology

    Patho Immunology

    Two Clean Queens · 34問 · 2年前

    Patho Immunology

    Patho Immunology

    34問 • 2年前
    Two Clean Queens

    Patho Hematology

    Patho Hematology

    Two Clean Queens · 100問 · 2年前

    Patho Hematology

    Patho Hematology

    100問 • 2年前
    Two Clean Queens

    Patho Hematology 2

    Patho Hematology 2

    Two Clean Queens · 76問 · 2年前

    Patho Hematology 2

    Patho Hematology 2

    76問 • 2年前
    Two Clean Queens

    Patho Respiratory

    Patho Respiratory

    Two Clean Queens · 100問 · 2年前

    Patho Respiratory

    Patho Respiratory

    100問 • 2年前
    Two Clean Queens

    Patho Respiratory 2

    Patho Respiratory 2

    Two Clean Queens · 54問 · 2年前

    Patho Respiratory 2

    Patho Respiratory 2

    54問 • 2年前
    Two Clean Queens

    Patho Cardiovascular

    Patho Cardiovascular

    Two Clean Queens · 100問 · 2年前

    Patho Cardiovascular

    Patho Cardiovascular

    100問 • 2年前
    Two Clean Queens

    Patho Cardiovascular 2

    Patho Cardiovascular 2

    Two Clean Queens · 56問 · 2年前

    Patho Cardiovascular 2

    Patho Cardiovascular 2

    56問 • 2年前
    Two Clean Queens

    Patho MSK

    Patho MSK

    Two Clean Queens · 52問 · 2年前

    Patho MSK

    Patho MSK

    52問 • 2年前
    Two Clean Queens

    Patho Acid Base

    Patho Acid Base

    Two Clean Queens · 35問 · 2年前

    Patho Acid Base

    Patho Acid Base

    35問 • 2年前
    Two Clean Queens

    Renal 2

    Renal 2

    Two Clean Queens · 10問 · 2年前

    Renal 2

    Renal 2

    10問 • 2年前
    Two Clean Queens

    Fluid Balance

    Fluid Balance

    Two Clean Queens · 43問 · 2年前

    Fluid Balance

    Fluid Balance

    43問 • 2年前
    Two Clean Queens

    Patho Endocrine

    Patho Endocrine

    Two Clean Queens · 100問 · 2年前

    Patho Endocrine

    Patho Endocrine

    100問 • 2年前
    Two Clean Queens

    Patho Endocrine 2

    Patho Endocrine 2

    Two Clean Queens · 42問 · 2年前

    Patho Endocrine 2

    Patho Endocrine 2

    42問 • 2年前
    Two Clean Queens

    Infections

    Infections

    Two Clean Queens · 58問 · 2年前

    Infections

    Infections

    58問 • 2年前
    Two Clean Queens

    Patho Shock

    Patho Shock

    Two Clean Queens · 31問 · 2年前

    Patho Shock

    Patho Shock

    31問 • 2年前
    Two Clean Queens

    GI

    GI

    Two Clean Queens · 100問 · 2年前

    GI

    GI

    100問 • 2年前
    Two Clean Queens

    GI 2

    GI 2

    Two Clean Queens · 18問 · 2年前

    GI 2

    GI 2

    18問 • 2年前
    Two Clean Queens

    Cancer

    Cancer

    Two Clean Queens · 54問 · 2年前

    Cancer

    Cancer

    54問 • 2年前
    Two Clean Queens

    Neuro

    Neuro

    Two Clean Queens · 94問 · 2年前

    Neuro

    Neuro

    94問 • 2年前
    Two Clean Queens

    Psychopathology

    Psychopathology

    Two Clean Queens · 20問 · 2年前

    Psychopathology

    Psychopathology

    20問 • 2年前
    Two Clean Queens

    Bone Pharm

    Bone Pharm

    Two Clean Queens · 77問 · 2年前

    Bone Pharm

    Bone Pharm

    77問 • 2年前
    Two Clean Queens

    Urology Pharm

    Urology Pharm

    Two Clean Queens · 68問 · 2年前

    Urology Pharm

    Urology Pharm

    68問 • 2年前
    Two Clean Queens

    Lifestyle Considerations Outline_Pharm

    Lifestyle Considerations Outline_Pharm

    Two Clean Queens · 97問 · 2年前

    Lifestyle Considerations Outline_Pharm

    Lifestyle Considerations Outline_Pharm

    97問 • 2年前
    Two Clean Queens

    Prescribing Basics Outline_Pharm

    Prescribing Basics Outline_Pharm

    Two Clean Queens · 23問 · 2年前

    Prescribing Basics Outline_Pharm

    Prescribing Basics Outline_Pharm

    23問 • 2年前
    Two Clean Queens

    Pharmacokinetics_Pharm

    Pharmacokinetics_Pharm

    Two Clean Queens · 31問 · 2年前

    Pharmacokinetics_Pharm

    Pharmacokinetics_Pharm

    31問 • 2年前
    Two Clean Queens

    Diabetes Pharm

    Diabetes Pharm

    Two Clean Queens · 100問 · 2年前

    Diabetes Pharm

    Diabetes Pharm

    100問 • 2年前
    Two Clean Queens

    Diabetes Pharm 2

    Diabetes Pharm 2

    Two Clean Queens · 41問 · 2年前

    Diabetes Pharm 2

    Diabetes Pharm 2

    41問 • 2年前
    Two Clean Queens

    Neuroendocrine Obesity Pharm

    Neuroendocrine Obesity Pharm

    Two Clean Queens · 100問 · 2年前

    Neuroendocrine Obesity Pharm

    Neuroendocrine Obesity Pharm

    100問 • 2年前
    Two Clean Queens

    Neuroendocrine Obesity Pharm 2

    Neuroendocrine Obesity Pharm 2

    Two Clean Queens · 43問 · 2年前

    Neuroendocrine Obesity Pharm 2

    Neuroendocrine Obesity Pharm 2

    43問 • 2年前
    Two Clean Queens

    Dermatology Pharm

    Dermatology Pharm

    Two Clean Queens · 106問 · 1年前

    Dermatology Pharm

    Dermatology Pharm

    106問 • 1年前
    Two Clean Queens

    Dermatology Pharm 2

    Dermatology Pharm 2

    Two Clean Queens · 24問 · 1年前

    Dermatology Pharm 2

    Dermatology Pharm 2

    24問 • 1年前
    Two Clean Queens

    Cardiac/Renal Pharm 1

    Cardiac/Renal Pharm 1

    Two Clean Queens · 100問 · 1年前

    Cardiac/Renal Pharm 1

    Cardiac/Renal Pharm 1

    100問 • 1年前
    Two Clean Queens

    Cardiac/Renal Pharm 2

    Cardiac/Renal Pharm 2

    Two Clean Queens · 100問 · 1年前

    Cardiac/Renal Pharm 2

    Cardiac/Renal Pharm 2

    100問 • 1年前
    Two Clean Queens

    Cardiac/Renal Pharm 3

    Cardiac/Renal Pharm 3

    Two Clean Queens · 86問 · 1年前

    Cardiac/Renal Pharm 3

    Cardiac/Renal Pharm 3

    86問 • 1年前
    Two Clean Queens

    Anticoagulants Pharm

    Anticoagulants Pharm

    Two Clean Queens · 46問 · 1年前

    Anticoagulants Pharm

    Anticoagulants Pharm

    46問 • 1年前
    Two Clean Queens

    Herbals

    Herbals

    Two Clean Queens · 48問 · 1年前

    Herbals

    Herbals

    48問 • 1年前
    Two Clean Queens

    N5220 Exam Pearls

    N5220 Exam Pearls

    Two Clean Queens · 100問 · 1年前

    N5220 Exam Pearls

    N5220 Exam Pearls

    100問 • 1年前
    Two Clean Queens

    DRIQ

    DRIQ

    Two Clean Queens · 67問 · 1年前

    DRIQ

    DRIQ

    67問 • 1年前
    Two Clean Queens

    Clinical Pearls Test 2

    Clinical Pearls Test 2

    Two Clean Queens · 76問 · 1年前

    Clinical Pearls Test 2

    Clinical Pearls Test 2

    76問 • 1年前
    Two Clean Queens

    Test 2 Seidel's Part I

    Test 2 Seidel's Part I

    Two Clean Queens · 94問 · 1年前

    Test 2 Seidel's Part I

    Test 2 Seidel's Part I

    94問 • 1年前
    Two Clean Queens

    Test 2 Seidel's Part II

    Test 2 Seidel's Part II

    Two Clean Queens · 98問 · 1年前

    Test 2 Seidel's Part II

    Test 2 Seidel's Part II

    98問 • 1年前
    Two Clean Queens

    NURS 5112 Exam Review Part 1

    NURS 5112 Exam Review Part 1

    Two Clean Queens · 66問 · 1年前

    NURS 5112 Exam Review Part 1

    NURS 5112 Exam Review Part 1

    66問 • 1年前
    Two Clean Queens

    NURS 5140 Exam 1 Review Part 1

    NURS 5140 Exam 1 Review Part 1

    Two Clean Queens · 100問 · 1年前

    NURS 5140 Exam 1 Review Part 1

    NURS 5140 Exam 1 Review Part 1

    100問 • 1年前
    Two Clean Queens

    NURS 5140 Exam 1 Review Application Part 1

    NURS 5140 Exam 1 Review Application Part 1

    Two Clean Queens · 100問 · 1年前

    NURS 5140 Exam 1 Review Application Part 1

    NURS 5140 Exam 1 Review Application Part 1

    100問 • 1年前
    Two Clean Queens

    NURS 5410 Exam 1 ApplicationPart 2

    NURS 5410 Exam 1 ApplicationPart 2

    Two Clean Queens · 50問 · 1年前

    NURS 5410 Exam 1 ApplicationPart 2

    NURS 5410 Exam 1 ApplicationPart 2

    50問 • 1年前
    Two Clean Queens

    Exam 2 NURS 5140

    Exam 2 NURS 5140

    Two Clean Queens · 8問 · 1年前

    Exam 2 NURS 5140

    Exam 2 NURS 5140

    8問 • 1年前
    Two Clean Queens

    NURS 5112 Exam 2 ChatGPT

    NURS 5112 Exam 2 ChatGPT

    Two Clean Queens · 90問 · 1年前

    NURS 5112 Exam 2 ChatGPT

    NURS 5112 Exam 2 ChatGPT

    90問 • 1年前
    Two Clean Queens

    Exam 3 NURS 5410 Anxiety

    Exam 3 NURS 5410 Anxiety

    Two Clean Queens · 66問 · 1年前

    Exam 3 NURS 5410 Anxiety

    Exam 3 NURS 5410 Anxiety

    66問 • 1年前
    Two Clean Queens

    Exam 3 NURS 5410 Pain

    Exam 3 NURS 5410 Pain

    Two Clean Queens · 44問 · 1年前

    Exam 3 NURS 5410 Pain

    Exam 3 NURS 5410 Pain

    44問 • 1年前
    Two Clean Queens

    Exam 3 NURS 5410 Sleep

    Exam 3 NURS 5410 Sleep

    Two Clean Queens · 72問 · 1年前

    Exam 3 NURS 5410 Sleep

    Exam 3 NURS 5410 Sleep

    72問 • 1年前
    Two Clean Queens

    NURS 5410 Exam 3 Quizzes

    NURS 5410 Exam 3 Quizzes

    Two Clean Queens · 25問 · 1年前

    NURS 5410 Exam 3 Quizzes

    NURS 5410 Exam 3 Quizzes

    25問 • 1年前
    Two Clean Queens

    Psychopharm Exam 1

    Psychopharm Exam 1

    Two Clean Queens · 71問 · 1年前

    Psychopharm Exam 1

    Psychopharm Exam 1

    71問 • 1年前
    Two Clean Queens

    Gero Psych Exam 1

    Gero Psych Exam 1

    Two Clean Queens · 62問 · 1年前

    Gero Psych Exam 1

    Gero Psych Exam 1

    62問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 1)

    Psychopharmacology Exam 2 (part 1)

    Two Clean Queens · 19問 · 1年前

    Psychopharmacology Exam 2 (part 1)

    Psychopharmacology Exam 2 (part 1)

    19問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 1)

    Peds Psych Exam 2 (part 1)

    Two Clean Queens · 19問 · 1年前

    Peds Psych Exam 2 (part 1)

    Peds Psych Exam 2 (part 1)

    19問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 2)

    Peds Psych Exam 2 (part 2)

    Two Clean Queens · 50問 · 1年前

    Peds Psych Exam 2 (part 2)

    Peds Psych Exam 2 (part 2)

    50問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 3)

    Peds Psych Exam 2 (part 3)

    Two Clean Queens · 67問 · 1年前

    Peds Psych Exam 2 (part 3)

    Peds Psych Exam 2 (part 3)

    67問 • 1年前
    Two Clean Queens

    Peds Psych Exam 2 (part 4)

    Peds Psych Exam 2 (part 4)

    Two Clean Queens · 20問 · 1年前

    Peds Psych Exam 2 (part 4)

    Peds Psych Exam 2 (part 4)

    20問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 2)

    Psychopharmacology Exam 2 (part 2)

    Two Clean Queens · 80問 · 1年前

    Psychopharmacology Exam 2 (part 2)

    Psychopharmacology Exam 2 (part 2)

    80問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 3)

    Psychopharmacology Exam 2 (part 3)

    Two Clean Queens · 46問 · 1年前

    Psychopharmacology Exam 2 (part 3)

    Psychopharmacology Exam 2 (part 3)

    46問 • 1年前
    Two Clean Queens

    Psychopharmacology Exam 2 (part 4)

    Psychopharmacology Exam 2 (part 4)

    Two Clean Queens · 22問 · 1年前

    Psychopharmacology Exam 2 (part 4)

    Psychopharmacology Exam 2 (part 4)

    22問 • 1年前
    Two Clean Queens

    Psychopharm Depressive Disorders

    Psychopharm Depressive Disorders

    Two Clean Queens · 86問 · 11ヶ月前

    Psychopharm Depressive Disorders

    Psychopharm Depressive Disorders

    86問 • 11ヶ月前
    Two Clean Queens

    Psychopharm Bipolar Disorder

    Psychopharm Bipolar Disorder

    Two Clean Queens · 58問 · 11ヶ月前

    Psychopharm Bipolar Disorder

    Psychopharm Bipolar Disorder

    58問 • 11ヶ月前
    Two Clean Queens

    Psychopharm Anxiety Disorders

    Psychopharm Anxiety Disorders

    Two Clean Queens · 32問 · 11ヶ月前

    Psychopharm Anxiety Disorders

    Psychopharm Anxiety Disorders

    32問 • 11ヶ月前
    Two Clean Queens

    Child Psych OCD/Gen Dysph

    Child Psych OCD/Gen Dysph

    Two Clean Queens · 34問 · 11ヶ月前

    Child Psych OCD/Gen Dysph

    Child Psych OCD/Gen Dysph

    34問 • 11ヶ月前
    Two Clean Queens

    Child Psych Eating Disorders 1

    Child Psych Eating Disorders 1

    Two Clean Queens · 49問 · 11ヶ月前

    Child Psych Eating Disorders 1

    Child Psych Eating Disorders 1

    49問 • 11ヶ月前
    Two Clean Queens

    Child Psych Eating Disorders 2

    Child Psych Eating Disorders 2

    Two Clean Queens · 14問 · 11ヶ月前

    Child Psych Eating Disorders 2

    Child Psych Eating Disorders 2

    14問 • 11ヶ月前
    Two Clean Queens

    Gero Mood Disorders

    Gero Mood Disorders

    Two Clean Queens · 19問 · 11ヶ月前

    Gero Mood Disorders

    Gero Mood Disorders

    19問 • 11ヶ月前
    Two Clean Queens

    Gero Anxiety Disorders

    Gero Anxiety Disorders

    Two Clean Queens · 13問 · 11ヶ月前

    Gero Anxiety Disorders

    Gero Anxiety Disorders

    13問 • 11ヶ月前
    Two Clean Queens

    Gero OCD & PTSD

    Gero OCD & PTSD

    Two Clean Queens · 15問 · 11ヶ月前

    Gero OCD & PTSD

    Gero OCD & PTSD

    15問 • 11ヶ月前
    Two Clean Queens

    Psychopharm Sleep

    Psychopharm Sleep

    Two Clean Queens · 34問 · 10ヶ月前

    Psychopharm Sleep

    Psychopharm Sleep

    34問 • 10ヶ月前
    Two Clean Queens

    Psychopharm ADHD

    Psychopharm ADHD

    Two Clean Queens · 20問 · 10ヶ月前

    Psychopharm ADHD

    Psychopharm ADHD

    20問 • 10ヶ月前
    Two Clean Queens

    Psychopharm Eating Disorders

    Psychopharm Eating Disorders

    Two Clean Queens · 6問 · 10ヶ月前

    Psychopharm Eating Disorders

    Psychopharm Eating Disorders

    6問 • 10ヶ月前
    Two Clean Queens

    Psychopharm Reward and Pleasure

    Psychopharm Reward and Pleasure

    Two Clean Queens · 32問 · 10ヶ月前

    Psychopharm Reward and Pleasure

    Psychopharm Reward and Pleasure

    32問 • 10ヶ月前
    Two Clean Queens

    Psychopharm Impulsivity/Compulsvity/Addiction

    Psychopharm Impulsivity/Compulsvity/Addiction

    Two Clean Queens · 7問 · 10ヶ月前

    Psychopharm Impulsivity/Compulsvity/Addiction

    Psychopharm Impulsivity/Compulsvity/Addiction

    7問 • 10ヶ月前
    Two Clean Queens

    Gero Exam 4 Review

    Gero Exam 4 Review

    Two Clean Queens · 81問 · 10ヶ月前

    Gero Exam 4 Review

    Gero Exam 4 Review

    81問 • 10ヶ月前
    Two Clean Queens

    Child Psych Sleep/Wake Disorders

    Child Psych Sleep/Wake Disorders

    Two Clean Queens · 58問 · 10ヶ月前

    Child Psych Sleep/Wake Disorders

    Child Psych Sleep/Wake Disorders

    58問 • 10ヶ月前
    Two Clean Queens

    Child Psych ODD/CD/SUD

    Child Psych ODD/CD/SUD

    Two Clean Queens · 49問 · 10ヶ月前

    Child Psych ODD/CD/SUD

    Child Psych ODD/CD/SUD

    49問 • 10ヶ月前
    Two Clean Queens

    問題一覧

  • 1

    Is the emotional response to real or perceived imminent threat. Often associated with surges of autonomic arousal necessary for fight or flight, thoughts of immediate danger, and escape behaviors.

    Fear

  • 2

    Is anticipation of future threat. More often associated with muscle tension and vigilance in preparation for future danger and cautious or avoidant behaviors.

    Anxiety

  • 3

    Normal fears from birth to 6 months

    -Loss of physical support -Loud noises -Large rapidly approaching objects

  • 4

    Normal fears 7-12 months

    Strangers

  • 5

    Normal fears 1-5 years old

    -Loud noises -Stroms -Animals -The dark -Separation from parents

  • 6

    Normals fears for 3-5 year olds

    -Monsters -Ghosts -Punishment

  • 7

    Normal fears for 6-12 year olds

    -Bodily injury/sickness -Burglars -Being sent to the principal -Punishment -Natural disasters -Failure/rejection

  • 8

    Normal fears 12-18 years old

    -Tests in school -Low social competence -Social evaluation -Social embarrassment -Psychological abnormality

  • 9

    Fear of being separated from a caregiver, fear of harm to self or caregiver when separated

    Seperation anxiety disorder

  • 10

    Consistent reduced communication (e.g., not speaking) in at least one environment despite ability to speak

    Selective mutism

  • 11

    Fear of negative evaluation

    Social anxiety disorder

  • 12

    Fear of a particular situation or object

    Specific phobias

  • 13

    Fear of the physiological sensations of anxiety and of having a panic attack

    Panic disorder

  • 14

    Worry about a broad range of topics

    Generalized anxiety disorder

  • 15

    Anxiety disorder in childhood adolescents predict a range of psychiatric disorders in adulthood

    ◦ Anxiety disorders, mood disorders, and substance abuse ◦ Lack of social competence ◦ Reduced social relationship functioning ◦ Reduced occupational functioning

  • 16

    ◦ Normal uncertainty and anxious or insecure attachment ◦ Maintenance of symptoms conditioned by fear, reinforcement ◦ Attachment theory - insecure mother-infant attachment and maternal sensitivity each separately predicted separation anxiety in children at age 6 years

    Etiology: Developmental and Behavioral

  • 17

    ◦ Dysregulation of fear and stress response system in the brain ◦ Behavioral inhibition - genetically based temperament trait characterized by response to a new or unfamiliar situation with avoidance, distress, caution, and/or reticence.

    Etiology: Biological

  • 18

    ◦ Parenting styles characterized by rejection, control, and intrusiveness are also likely related to increased anxiety in youth ◦ Parental modeling and exposure to negative information (SOC, Panic disorder, GAD)

    Etiology: Environmental

  • 19

    Hallmarks of Anxiety in Children and Adolescents

    • Somatic symptoms: stomach aches, headaches, sore muscles • Cognitive symptoms: difficulty with attention, concentration, organization and/or decision making • Social avoidance: school refusal • Affective symptoms: irritability, tearfulness, aggression (in adolescents), increased temper tantrums (in younger children) • Avoidance of age appropriate tasks • Noticeable decline in school performance or increased procrastination • Inability to complete assignments on time • Increased need for routines or increases distress in variations to routine; attempts to control others’ behaviors • Restlessness or increased startle response • Sleep disturbances

  • 20

    Ages 8-19: GAD, panic/agoraphobia, social phobia, SAD, OCD, and physical symptoms, harm avoidance

    Multidimensional Anxiety Scale for Children (MASC)

  • 21

    Ages 9-18; GAD SOC, phobic disorders, SAD

    Screen for Child Anxiety and Related Emotional Disorders (SCARED)

  • 22

    Ages: 8-15; GAD, panic/agoraphobia, social phobia, SAD, OCD, and physical injury fears

    Spence Children’s Anxiety Scale (SCAS)

  • 23

    Ages 2.5-6.5 (Based on the SCAS)

    Preschool Anxiety Scale

  • 24

    Ages 6-17; GAD, general and social phobia, SAD

    Pediatric Anxiety Rating Scale (PARS)

  • 25

    When moderate to severe anxiety symptoms persist what SSRIs can we use and what age range?

    -FDA approved for 7+ -Citalopram -Fluoxetine -Fluvoxamine -Paroxetine -Sertraline

  • 26

    What are the SNRIs for child and adolescents?

    -Venlafaxine -Duloxetine

  • 27

    Benzos used in child and adolescents?

    -Clonazepam -Alprazolam -Lorazepam

  • 28

    Non-benzodiazepine (0.2-0.6 mg/kg; BID or TID – indicated for OCD, GSD, SOC) SE: lightheadedness, dizziness, nausea, sedation

    Buspirone

  • 29

    -Tertiary TCA (2.0-5.0 mg/kg; daily or BID – indicated for OCD and school refusal) -SE: Anticholinergic

    Clomipramine

  • 30

    -Tertiary TCA (2.0-5.0 mg/kg; daily or BID – indicated for GAD and panic disorder) -SE: cardiac toxicity and EKG changes

    Imipramine

  • 31

    -Secondary TCA (2.0-5.0 mg/kg; daily or BID – indicated for OCD) -SE: cardiac toxicity and EKG changes

    Despiramine

  • 32

    -Developmentally inappropriate and excessive fear or anxiety concerning separation from those to whom the individual is attached -Recurrent excessive distress when anticipating or experiencing separation from home or from major attachment figures. -Persistent and excessive worry about losing major attachment figures or about possible harm to them -Persistent and excessive worry about experiencing an untoward event (e.g., getting lost, being kidnapped, having an accident, becoming ill) that causes separation from a major attachment figure. -Persistent reluctance or refusal to go out because of fear of separation. -Persistent and excessive fear of or reluctance about being alone or without major attachment figures at home or in other settings. -Persistent reluctance or refusal to sleep away from home or to go to sleep without being near a major attachment figure. -Repeated nightmares involving separation. -Repeated complaints of physical symptoms (e.g., headaches, stomachaches, nausea, vomiting) when separation from major attachment figures occurs or is anticipated. -The fear, anxiety, or avoidance is persistent, lasting at least 4 weeks -The disturbance causes clinically significant distress or impairment -The disturbance is not better explained by another mental disorder

    DSM-5 Criteria: Separation Anxiety Disorder (SAD)

  • 33

    Duration of Separation Anxiety Disorder (SAD)

    Duration: 4-6 weeks in children and adolescents; 6 months in adults

  • 34

    Epidemiology of Separation Anxiety Disorder (SAD)

    Overall prevalence: 3-5% 6 to 12-month prevalence -In children: 4% -In adolescents: 1.6% Decreases in prevalence with age ◦ Most prevalent in children <12 years old Equally common in males and females in clinical samples ◦ Females>males in community samples 75% of children with SAD exhibit school avoidance behaviors ◦ Absenteeism ◦ Refusal

  • 35

    Separation anxiety is a normal developmental phenomenon in

    Children ages 6–30 months, with intensification between 13 and 18 months of age

  • 36

    -Consistent failure to speak in specific social situations in which there is an expectation for speaking (e.g., at school) despite speaking in other situations. -The disturbance interferes with educational or occupational achievement or with social communication. -The duration of the disturbance is at least 1 month (not limited to the first month of school). -The failure to speak is not attributable to a lack of knowledge of, or comfort with, the spoken language required in the social situation. -The disturbance is not better explained by a communication disorder (e.g., childhood-onset fluency disorder) and does not occur exclusively during the course of autism spectrum disorder, schizophrenia, or another psychotic disorder.

    DSM-5 Criteria: Selective Mutism

  • 37

    Relatively rare ◦ Prevalence between 0.03%-1% depending on the setting (e.g., clinic vs. school vs. community) Most likely to occur in young children rather than adolescents ◦ Onset usually before age 5; may not be clinically relevant until attendance in school -Common in males and females -Persistence varies; however, most outgrow -Longitudinal course is unknown

    Epidemiology and Etiology: Selective Mutism

  • 38

    ◦ Shyness ◦ Behavioral inhibition ◦ Receptive language difficulties (although still within normal range) ◦ Social isolation/anxiety

    Temperamental Risks: Selective Mutism

  • 39

    ◦ Parental modeling ◦ Overprotective parenting or more controlling ◦ Genetic factors ◦ May be shared genetic factors that are associated with social anxiety disorder

    Environmental Risks: Selective Mutism

  • 40

    Noted usually at the start of kindergarten or 1st grade ◦ Most are diagnosed between ages 3-8 -Resolves by age of 10; if continues beyond 12 years, full recoverly less likely -SM leads to complications in academic achievement and peer relationships ◦ May lead to placement in special education classes or schools -May develop social anxiety disorder in adulthood

    Course and Prognosis: Selective Mutism

  • 41

    -Marked fear or anxiety about one or more social situations in which the individual is exposed to possible scrutiny by others. -The individual fears that he or she will act in a way or show anxiety symptoms that will be negatively evaluated -The social situations almost always provoke fear or anxiety. -The social situations are avoided or endured with intense fear or anxiety. -The fear or anxiety is out of proportion to the actual threat posed by the social situation/context -Must last 6 months or more

    DSM-5 Criteria: Social anxiety disorder (SAD)

  • 42

    Blushing in a hallmark sign of this disorder

    Social Anxiety Disorder (SAD)

  • 43

    -Prevalence: 5% in children and 16% in youths 13-17 years -More common in girls and younger children

    Epidemiology: Specific Phobias

  • 44

    Prevalence: 2-5% children, 9% in adolescents ◦ Lifetime: 16%

    Epidemiology: Social Anxiety Disorder (SAD)

  • 45

    Median age of onset: 13 years ◦ Age of onset between 8 and 15 years for 75% of individuals ◦ May follow a stressful or humiliating experience, or an experience which may require a new social role ◦ Adolescents may have broad patters of fear and avoidance, in comparison to younger children ◦ 30% experience remission of symptoms within 1 year ◦ 50% within a few years ◦ 60% without a specific treatment, it may take several years or longer

    Development and Course: Social Anxiety Disorder (SAD) and Specific Phobias

  • 46

    ◦ Tends to begin in adolescence ◦ Stressful life events may play a role ◦ Impact functioning into adulthood if symptoms persist (Similar to SAD outcomes)

    Course and Prognosis: Social Anxiety Disorder

  • 47

    ◦ Can begin at any time during development ◦ Usually associated with an unexpected panic attack or traumatic event ◦ Often resolve spontaneously ◦ Those with natural-environment type phobias tend to fare poorly and are more difficult to treat than those with animal-type phobias

    Course and Prognosis: Specific Phobias

  • 48

    Characterized by social evaluative concerns; fear that the individual makes other people uncomfortable

    Taijin kyofusho syndrome

  • 49

    Recurrent unexpected panic attacks. A panic attack is an abrupt surge of intense fear or intense discomfort that reaches a peak within minutes, and during which time four (or more) of the following symptoms occur: 1. Palpitations, pounding heart, or accelerated heart rate. 2. Sweating. 3. Trembling or shaking. 4. Sensations of shortness of breath or smothering. 5. Feelings of choking. 6. Chest pain or discomfort. 7. Nausea or abdominal distress. 8. Feeling dizzy, unsteady, light-headed, or faint. 9. Chills or heat sensations. 10. Paresthesias (numbness or tingling sensations). 11. Derealization (feelings of unreality) or depersonalization (being detached from oneself). 12. Fear of losing control or “going crazy.” 13. Fear of dying. At least one of the attacks has been followed by 1 month (or more) of one or both of the following: 1. Persistent concern or worry about additional panic attacks or their consequences 2. A significant maladaptive change in behavior related to the attacks

    DSM-5 Criteria: Panic Disorder

  • 50

    Age of onset in U.S.: 20-24 years old ◦ Small numbers in childhood, rare ◦ More common in adolescents 12-month prevalence: 2-3% in adolescents and adults in U.S. and European countries Ethnic differences within the U.S. ◦ Lower rates: Latino, African American, Caribbean blacks, and Asian Americans (0.1-0.8%) ◦ Higher rates: American Indians Male:Female ratio is 1:2 ◦ Occurs is adolescence and usually observable prior to age 14 Possibly a genetic component based on twin studies Panic disorder increases in adolescence and peaks during adulthood, often declining in the older adult If untreated, can wax and wane for years

    Epidemiology: Panic Disorder

  • 51

    -Natural history and course are unclear -Likely to be a chronic disorder as often co-occurring with other anxiety and mood disorders, including ADHD -Prepubertal onset usually signals greater severity -Can begin at the onset of or during an episode of major depression or SAD

    Course and Prognosis: Panic Disorder

  • 52

    -Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at least 6 months, about a number of events or activities (such as work or school performance). -The individual finds it difficult to control the worry. -The anxiety and worry are associated with three (or more) of the following six symptoms (with at least some symptoms having been present for more days than not for the past 6 months): 1. Restlessness or feeling keyed up or on edge. 2. Being easily fatigued. 3. Difficulty concentrating or mind going blank. 4. Irritability 5. Muscle tension. 6. Sleep disturbance (difficulty falling or staying asleep, or restless, unsatisfying sleep). -The anxiety, worry, or physical symptoms cause clinically significant distress or impairment in social, occupational, or other important areas of functioning

    DSM-5 Criteria: Generalized Anxiety Disorder

  • 53

    Common symptoms may include ◦ Nail biting ◦ Hair pulling ◦ Thumb sucking ◦ Licking around the mouth ◦ Somatic symptoms (see picture)

    Generalized Anxiety Disorder

  • 54

    Average age of onset: early 30s Transient symptoms may be developing in children due to other anxiety disorders or depression Prevalence: 1 -3% in adolescents Male: Female ratio: 1:2

    Epidemiology: Generalized Anxiety Disorder

  • 55

    -Chronic disorder with low rates of full remission -Improvement is variable due to the waxing and waning nature of the disorder (with or without treatment) If diagnosed in childhood ◦ Likely due to heritable traits ◦ May exhibit more severe symptoms and impairment ◦ Increased risk for the development of a range of disorders across the life span

    Course and Prognosis: Generalized Anxiety Disorder

  • 56

    What phobias are equal in boys and girls?

    Blood-injection injury